Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Immunome (IMNM) Leases (2023 - 2025)

Immunome's Leases history spans 3 years, with the latest figure at $3.0 million for Q4 2025.

  • For Q4 2025, Leases fell 30.39% year-over-year to $3.0 million; the TTM value through Dec 2025 reached $3.0 million, down 30.39%, while the annual FY2025 figure was $3.0 million, 30.39% down from the prior year.
  • Leases reached $3.0 million in Q4 2025 per IMNM's latest filing, down from $3.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $4.3 million in Q4 2024 to a low of $174000.0 in Q2 2023.
  • Average Leases over 3 years is $2.3 million, with a median of $2.5 million recorded in 2024.
  • Peak YoY movement for Leases: surged 1350.0% in 2024, then plummeted 30.39% in 2025.
  • A 3-year view of Leases shows it stood at $1.6 million in 2023, then skyrocketed by 173.53% to $4.3 million in 2024, then tumbled by 30.39% to $3.0 million in 2025.
  • Per Business Quant, the three most recent readings for IMNM's Leases are $3.0 million (Q4 2025), $3.1 million (Q3 2025), and $3.3 million (Q2 2025).